Pregnancy Anemia
13
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
15%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Non-invasive Point-Of-Care Hemoglobin Testing In An Obstetric Population
Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy
Iron Deficiency Anemia in the Second and Third Trimester of Pregnancy
Non-invasive Detection of Iron Deficiency in Obstetrics
The Effect of Vitamin C for Iron Supplementation During Pregnancy with Risk of Anemia
Effect of Spinal Anesthesia in Elective Cesarean Cases on Frontal QRS Angle in Anemic and Non-Anemic Patients
Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia
Prospective Study on Feto-maternal outcoMe In aNemIc womEn
Adherence of Iron Succinylate Therapy in Pregnancy
Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis
Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital
Vitamin B12 Pregnancy Supplementation
Prevalence Study of the Etiology of Pregnancy Anemia